Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $66.8B |
| FY2017, ended Dec 31, 2017 | $85.4B |
| FY2018, ended Dec 31, 2018 | $80.4B |
| FY2019, ended Dec 31, 2019 | $101B |
| FY2020, ended Dec 31, 2020 | $97.4B |
| FY2021, ended Dec 31, 2021 | $124B |
| FY2022, ended Dec 31, 2022 | $110B |
| FY2023, ended Dec 31, 2023 | $136B |
| FY2024, ended Dec 31, 2024 | $209B |
| FY2025, ended Dec 31, 2025 | $254B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $204B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $35.4B |
| FY2017, ended Dec 31, 2017 | $36.9B |
| FY2018, ended Dec 31, 2018 | $40.3B |
| FY2019, ended Dec 31, 2019 | $43.6B |
| FY2020, ended Dec 31, 2020 | $36.1B |
| FY2021, ended Dec 31, 2021 | $42.4B |
| FY2022, ended Dec 31, 2022 | $52.9B |
| FY2023, ended Dec 31, 2023 | $60.5B |
| FY2024, ended Dec 31, 2024 | $65.9B |
| FY2025, ended Dec 31, 2025 | $72.2B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $77.6B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $5.38B | $6.92B |
| FY2017, ended Dec 31, 2017 | $2.75B | $12.5B |
| FY2018, ended Dec 31, 2018 | $6.92B | $7.62B |
| FY2019, ended Dec 31, 2019 | $6.76B | $12.0B |
| FY2020, ended Dec 31, 2020 | $3.13B | $4.11B |
| FY2021, ended Dec 31, 2021 | $8.06B | $13.1B |
| FY2022, ended Dec 31, 2022 | $7.51B | $19.2B |
| FY2023, ended Dec 31, 2023 | $8.37B | $17.0B |
| FY2024, ended Dec 31, 2024 | $10.1B | $12.1B |
| FY2025, ended Dec 31, 2025 | $10.8B | $16.0B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $12.3B | $13.9B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $25.5B |
| FY2017, ended Dec 31, 2017 | $33.3B |
| FY2018, ended Dec 31, 2018 | $27.8B |
| FY2019, ended Dec 31, 2019 | $24.4B |
| FY2020, ended Dec 31, 2020 | $33.0B |
| FY2021, ended Dec 31, 2021 | $21.5B |
| FY2022, ended Dec 31, 2022 | $33.4B |
| FY2023, ended Dec 31, 2023 | $46.6B |
| FY2024, ended Dec 31, 2024 | $40.6B |
| FY2025, ended Dec 31, 2025 | $47.8B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $43.2B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $52.6B |
| FY2017, ended Dec 31, 2017 | $59.1B |
| FY2018, ended Dec 31, 2018 | $61.5B |
| FY2019, ended Dec 31, 2019 | $64.3B |
| FY2020, ended Dec 31, 2020 | $44.8B |
| FY2021, ended Dec 31, 2021 | $40.9B |
| FY2022, ended Dec 31, 2022 | $43.9B |
| FY2023, ended Dec 31, 2023 | $49.2B |
| FY2024, ended Dec 31, 2024 | $51.1B |
| FY2025, ended Dec 31, 2025 | $57.8B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $60.0B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 25.6% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 901M |
| FY2017, ended Dec 31, 2017 | 860M |
| FY2018, ended Dec 31, 2018 | 843M |
| FY2019, ended Dec 31, 2019 | 808M |
| FY2020, ended Dec 31, 2020 | 806M |
| FY2021, ended Dec 31, 2021 | 759M |
| FY2022, ended Dec 31, 2022 | 744M |
| FY2023, ended Dec 31, 2023 | 724M |
| FY2024, ended Dec 31, 2024 | 703M |
| FY2025, ended Dec 31, 2025 | 687M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 671M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $4.40B | $254M | $177M |
| FY2017, ended Dec 31, 2017 | $4.30B | $282M | $129M |
| FY2018, ended Dec 31, 2018 | $1.60B | $283M | $87.0M |
| FY2019, ended Dec 31, 2019 | — | $283M | $86.0M |
| FY2020, ended Dec 31, 2020 | $1.03B | $249M | $44.0M |
| FY2021, ended Dec 31, 2021 | $7.65B | $330M | $64.0M |
| FY2022, ended Dec 31, 2022 | $3.50B | $375M | $56.0M |
| FY2023, ended Dec 31, 2023 | $3.65B | $450M | $28.0M |
| FY2024, ended Dec 31, 2024 | $6.02B | $504M | $100M |
| FY2025, ended Dec 31, 2025 | $5.81B | $551M | $57.0M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $6.70B | $636M | $23.0M |
Valuation
At current price- Market Cap
- $210B
- P/E
- 17.1×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 2.7×
- Price / Book
- 5.9×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $77.6B
- Revenue Growth YoY
- 10.2%
- Revenue CAGR 3Y
- 11.0%
- Revenue CAGR 5Y
- 14.9%
- EPS Growth YoY
- 19.2%
- Net Income Growth YoY
- 16.3%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- —
- Net Margin
- 15.8%
- FCF Margin
- 17.9%
- Return on Equity
- 35.9%
Earnings
Trailing 12 months- Net Income
- $12.3B
- EPS (diluted)
- $17.75
- EBITDA
- —. Operating income + depreciation & amortization
- Operating Income
- —
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $43.2B
- Total Debt
- $60.0B
- Net Debt
- $16.8B
- Total Assets
- $310B
- Total Liabilities
- $274B
- Shareholders' Equity
- $35.8B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $17.6B
- Capital Expenditure
- $3.72B
- Free Cash Flow
- $13.9B
Dividends and risk
Last 12 months- Dividend Yield
- 1.2%
- Dividend / Share
- $3.67
- Beta (5Y)
- 1.08
Every ratio is calculated from the company’s reported figures.